T. Dennie

Activity of oxaliplatin plus capecitabine (CapeOx) with lapatinib for metastatic colorectal cancer: results from two patients treated on a clinical study.

K. Holen, T. Mohammed, T. Dennie, 2011, Clinical advances in hematology & oncology : H&O.

A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma

N. Burwick, P. Becker, W. Bensinger, 2016, Blood Cancer Journal.

A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid tumors.

R. Fleming, C. Bowen, D. Alberti, 2011, Clinical colorectal cancer.

Metastatic, Her-2 Amplified Lacrimal Gland Carcinoma with Response to Lapatinib Treatment

T. Dennie, 2015, Case reports in oncological medicine.

Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.

J. Kolesar, T. Dennie, 2009, Clinical therapeutics.

A Phase I/II Study Of Fludarabine, Cyclophosphamide, Rituximab and Vorinostat Followed By Rituximab and Vorinostat Maintenance Therapy In Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia (CLL) Or Small Lymphocytic Leukemia (SLL)

D. Maloney, J. Pagel, S. Petersdorf, 2013 .

A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid tumors.

R. Fleming, C. Bowen, D. Alberti, 2011, Clinical colorectal cancer.

A phase I study of capecitabine, oxaliplatin (CapOx), and lapatinib (L) in metastatic or advanced solid tumors.

G. Wilding, R. Fleming, C. Bowen, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.